241 related articles for article (PubMed ID: 7391583)
1. Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice.
Steinberg AD; Roths JB; Murphy ED; Steinberg RT; Raveche ES
J Immunol; 1980 Aug; 125(2):871-3. PubMed ID: 7391583
[TBL] [Abstract][Full Text] [Related]
2. Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease.
Seaman WE; Wofsy D; Greenspan JS; Ledbetter JA
J Immunol; 1983 Apr; 130(4):1713-8. PubMed ID: 6187819
[TBL] [Abstract][Full Text] [Related]
3. Studies of lymphoproliferation in MRL-lpr/lpr mice.
Smathers PA; Santoro TJ; Chused TM; Reeves JP; Steinberg AD
J Immunol; 1984 Oct; 133(4):1955-61. PubMed ID: 6332142
[TBL] [Abstract][Full Text] [Related]
4. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
Merino R; Iwamoto M; Fossati L; Izui S
J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378
[TBL] [Abstract][Full Text] [Related]
5. Thymic influences on autoimmunity in MRL-lpr mice.
Wofsy D; Ledbetter JA; Roubinian JR; Seaman WE; Talal N
Scand J Immunol; 1982 Jul; 16(1):51-8. PubMed ID: 6981841
[TBL] [Abstract][Full Text] [Related]
6. Effects of neonatal thymectomy and splenectomy on survival and regulation of autoantibody formation in NZB/NZW F1 mice.
Roubinian JR; Papoian R; Talal N
J Immunol; 1977 May; 118(5):1524-9. PubMed ID: 870559
[TBL] [Abstract][Full Text] [Related]
7. The effect of thymectomy on lupus-prone mice.
Hang L; Theofilopoulos AN; Balderas RS; Francis SJ; Dixon FJ
J Immunol; 1984 Apr; 132(4):1809-13. PubMed ID: 6142069
[TBL] [Abstract][Full Text] [Related]
8. Evidence for thymic regulation of autoimmunity in BXSB mice: acceleration of disease by neonatal thymectomy.
Smith HR; Chused TM; Smathers PA; Steinberg AD
J Immunol; 1983 Mar; 130(3):1200-4. PubMed ID: 6600477
[TBL] [Abstract][Full Text] [Related]
9. Autoimmunity to histones, ubiquitin, and ubiquitinated histone H2A in NZB x NZW and MRL-lpr/lpr mice. Anti-histone antibodies are concentrated in glomerular eluates of lupus mice.
Elouaai F; Lulé J; Benoist H; Appolinaire-Pilipenko S; Atanassov C; Muller S; Fournié GJ
Nephrol Dial Transplant; 1994; 9(4):362-6. PubMed ID: 8084447
[TBL] [Abstract][Full Text] [Related]
10. Distinct clonotypes of anti-DNA antibodies in mice with lupus nephritis.
Yoshida H; Yoshida M; Izui S; Lambert PH
J Clin Invest; 1985 Aug; 76(2):685-94. PubMed ID: 3875630
[TBL] [Abstract][Full Text] [Related]
11. Selective reduction of V alpha 14+ NK T cells associated with disease development in autoimmune-prone mice.
Mieza MA; Itoh T; Cui JQ; Makino Y; Kawano T; Tsuchida K; Koike T; Shirai T; Yagita H; Matsuzawa A; Koseki H; Taniguchi M
J Immunol; 1996 May; 156(10):4035-40. PubMed ID: 8621946
[TBL] [Abstract][Full Text] [Related]
12. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
Matsumoto K; Watanabe N; Akikusa B; Kurasawa K; Matsumura R; Saito Y; Iwamoto I; Saito T
Arthritis Rheum; 2003 Feb; 48(2):486-94. PubMed ID: 12571859
[TBL] [Abstract][Full Text] [Related]
13. IL-12-encoding plasmid has a beneficial effect on spontaneous autoimmune disease in MRL/MP-lpr/lpr mice.
Hagiwara E; Okubo T; Aoki I; Ohno S; Tsuji T; Ihata A; Ueda A; Shirai A; Okuda K; Miyazaki J; Ishigatsubo Y
Cytokine; 2000 Jul; 12(7):1035-41. PubMed ID: 10880249
[TBL] [Abstract][Full Text] [Related]
14. Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI.
Liu W; Szalai A; Zhao L; Liu D; Martin F; Kimberly RP; Zhou T; Carter RH
Arthritis Rheum; 2004 Jun; 50(6):1884-96. PubMed ID: 15188365
[TBL] [Abstract][Full Text] [Related]
15. Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice.
Sadanaga A; Nakashima H; Masutani K; Miyake K; Shimizu S; Igawa T; Sugiyama N; Niiro H; Hirakata H; Harada M
Arthritis Rheum; 2005 Dec; 52(12):3987-96. PubMed ID: 16320345
[TBL] [Abstract][Full Text] [Related]
16. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse.
Zhou T; Bluethmann H; Eldridge J; Berry K; Mountz JD
J Immunol; 1993 Apr; 150(8 Pt 1):3651-67. PubMed ID: 7682246
[TBL] [Abstract][Full Text] [Related]
17. [Functional analysis of an autoantigen reactive B cell clone derived from MRL/MP-lpr/lpr mice].
Kobayashi K; Hamano T; Kakishita E
Ryumachi; 1996 Dec; 36(6):844-55. PubMed ID: 9122824
[TBL] [Abstract][Full Text] [Related]
18. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
[TBL] [Abstract][Full Text] [Related]
19. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice.
Sadanaga A; Nakashima H; Akahoshi M; Masutani K; Miyake K; Igawa T; Sugiyama N; Niiro H; Harada M
Arthritis Rheum; 2007 May; 56(5):1618-28. PubMed ID: 17469144
[TBL] [Abstract][Full Text] [Related]
20. MRL mice produce anti-Su autoantibody, a specificity associated with systemic lupus erythematosus.
Treadwell EL; Cohen P; Williams D; O'Brien K; Volkman A; Eisenberg R
J Immunol; 1993 Jan; 150(2):695-9. PubMed ID: 8419494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
